Potential of E-Cigarettes to Improve Public Health: Expert Opinion

Sep.19.2022
Potential of E-Cigarettes to Improve Public Health: Expert Opinion
Tikki Pangestu believes e-cigarettes have potential to improve public health, citing data from independent UK studies.

Tikki Pangestu, a former director of policy research and cooperation at the World Health Organization, discussed the potential of e-cigarettes to improve public health. Professor Pangestu made a positive statement during an online discussion titled "Reducing Smoking Harm: Is it Possible to Reduce Tobacco Harm?


Professor Tikki Pang is currently a visiting professor at the Yong Loo Lin School of Medicine at the National University of Singapore. Prior to serving as Director of the World Health Organization, he was a professor at the Lee Kuan Yew School of Public Policy and a biomedical professor at the University of Malaya.


In his academic career spanning 30 years, Professor Peng has published over 250 scientific articles and 12 books covering topics such as epidemiology, pathogenesis, laboratory diagnosis, prevention of infectious diseases, biosafety, and dual-use research. He is recognized as an expert in public health both domestically and internationally.


According to Tikki Pang, there are still nearly 70 million smokers in his country, which has resulted in economic costs for the nation and significant socioeconomic burden for individuals.


He said, "From a public health and socio-economic perspective, this issue requires a strategic intervention and policy to reduce smoking rates in Indonesia.


Compared to products such as nicotine replacement therapy, interventions using products that promote harm reduction concepts are more effective for those who wish to quit smoking. This is a key strategy in addressing this highly complex issue. The products that result from technological advances and innovation have enormous potential.


Professor Peng cites facts and data from independent research in the UK to urge Indonesian lawmakers to accept electronic cigarettes, snus, and heated tobacco products.


The road to a healthier nation depends on the government ensuring that adult smokers have easy access to lesser harmful new nicotine products and that the information provided is accurate and truthful.


British cancer expert Peter Harper agrees with this. He commented, "You smoke to satisfy your need for nicotine, but you die from smoking. Quitting smoking immediately is one solution. However, current strategies are not effective. Innovative products provide solutions for those struggling to quit, while reducing the overall impact on well-being.


Statement:


This article is compiled from third-party information and is intended solely for communication and learning within the industry.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in our translation abilities, the translated article may not perfectly reflect the original text. Please refer to the original article for accuracy.


2FIRSTS holds the same views and positions as the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and stances.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
A smoke-free nicotine policy report argues that tobacco harm reduction should move beyond product bans and health warnings into tax policy, insurance pricing and risk-based regulation. While some projections remain open to debate, the report highlights a wider challenge: nicotine products, technologies and consumer behavior have changed sharply over the past decade, and regulatory systems may need new tools to better align tobacco control with harm-reduction goals.
Jun.08
Tobacco Farming in the New Nicotine Era: Why Indian Farmers Struggle to Transition — Contributed by Samrat Chowdhery
Tobacco Farming in the New Nicotine Era: Why Indian Farmers Struggle to Transition — Contributed by Samrat Chowdhery
In this contributed article to 2Firsts, Mumbai-based journalist and harm reduction advocate Samrat Chowdhery examines India’s tobacco transition from the perspective of agriculture, supply chains and regulation. As noted by 2Firsts, India offers a relevant case for understanding how new nicotine technologies may affect not only consumption, trade and policy, but also tobacco farming.
Special Report
May.29
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
As cigarette volumes continue to decline, U.S. convenience-store operators are reconfiguring backbar space to accommodate modern oral nicotine products such as nicotine pouches. Industry data show nicotine pouches have become one of the fastest-growing nicotine categories while generating higher margins for retailers.
Jun.12
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11